Gengrong Lin

1.3k total citations
36 papers, 1.2k citations indexed

About

Gengrong Lin is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Gengrong Lin has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 21 papers in Epidemiology and 18 papers in Pharmacology. Recurrent topics in Gengrong Lin's work include Antimicrobial Resistance in Staphylococcus (22 papers), Pneumonia and Respiratory Infections (21 papers) and Antibiotics Pharmacokinetics and Efficacy (18 papers). Gengrong Lin is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (22 papers), Pneumonia and Respiratory Infections (21 papers) and Antibiotics Pharmacokinetics and Efficacy (18 papers). Gengrong Lin collaborates with scholars based in United States, Switzerland and India. Gengrong Lin's co-authors include Peter C. Appelbaum, Glenn A. Pankuch, Michael R. Jacobs, Kim Credito, Saralee Bajaksouzian, Lois M. Ednie, Dianne B. Hoellman, Harald Seifert, Catherine Clark and Kathy Smith and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Drugs.

In The Last Decade

Gengrong Lin

35 papers receiving 1.1k citations

Peers

Countries citing papers authored by Gengrong Lin

Since Specialization

Citations

This map shows the geographic impact of Gengrong Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gengrong Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gengrong Lin more than expected).

Fields of papers citing papers by Gengrong Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gengrong Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gengrong Lin. The network helps show where Gengrong Lin may publish in the future.

Co-authorship network of co-authors of Gengrong Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Gengrong Lin. A scholar is included among the top collaborators of Gengrong Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gengrong Lin. Gengrong Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Activity of telavancin compared to other agents against coagulase-negative staphylococci with different resistotypes by time kill 2012 ·Diagnostic Microbiology and Infectious Disease ·Gengrong Lin, Glenn A. Pankuch, Peter C. Appelbaum, Klaudia Kosowska-Shick	8
2	Activity of ACHN-490 Tested Alone and in Combination with Other Agents against Pseudomonas aeruginosa 2011 ·Antimicrobial Agents and Chemotherapy ·Glenn A. Pankuch, Gengrong Lin, (unknown), Eliana S. Armstrong, Peter C. Appelbaum, Klaudia Kosowska-Shick	18
3	Time-Kill Activity of the Streptogramin NXL 103 against Gram-Positive and -Negative Bacteria 2011 ·Antimicrobial Agents and Chemotherapy ·Glenn A. Pankuch, Gengrong Lin, Catherine Clark, Peter C. Appelbaum	7
4	Antistaphylococcal Activities of Dihydrophthalazine Dihydrofolates, a Family of Novel Antibacterial Drugs, by Time-Kill 2008 ·46th Annual Meeting ·Gengrong Lin	1
5	Activity of ceftobiprole compared with those of other agents against Staphylococcus aureus strains with different resistotypes by time-kill analysis 2007 ·Diagnostic Microbiology and Infectious Disease ·Gengrong Lin, Peter C. Appelbaum	17
6	Activity of Daptomycin Alone and in Combination with Rifampin and Gentamicin against Staphylococcus aureus Assessed by Time-Kill Methodology 2007 ·Antimicrobial Agents and Chemotherapy ·Kim Credito, Gengrong Lin, Peter C. Appelbaum	71
7	Activities of Ceftobiprole, a Novel Broad-Spectrum Cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis 2006 ·Antimicrobial Agents and Chemotherapy ·Tatiana Bogdanovich, Catherine Clark, Lois M. Ednie, Gengrong Lin, Kathy Smith, Stuart Shapiro, Peter C. Appelbaum	31
8	Activity of Retapamulin against Streptococcus pyogenes and Staphylococcus aureus Evaluated by Agar Dilution, Microdilution, E-Test, and Disk Diffusion Methodologies 2006 ·Antimicrobial Agents and Chemotherapy ·Glenn A. Pankuch, Gengrong Lin, Dianne B. Hoellman, Caryn E. Good, Michael R. Jacobs, Peter C. Appelbaum	23
9	Activity of the new quinolone WCK 771 against pneumococci 2005 ·Clinical Microbiology and Infection ·Peter C. Appelbaum, Glenn A. Pankuch, Bülent Bozdoğan, Gengrong Lin, Michael R. Jacobs, Mahesh Patel, (unknown), Mohammad Jafri, N. J. DE SOUZA, (unknown)	15
10	Activity of five quinolones, three macrolides and telithromycin against 12 Haemophilus influenzae strains with different resistance phenotypes 2005 ·Clinical Microbiology and Infection ·Glenn A. Pankuch, Gengrong Lin, Peter C. Appelbaum	4
11	Antistaphylococcal Activity of Dalbavancin, an Experimental Glycopeptide 2005 ·Antimicrobial Agents and Chemotherapy ·Gengrong Lin, Kim Credito, Lois M. Ednie, Peter C. Appelbaum	77
12	Antistaphylococcal Activity of DX-619, a New Des-F(6)-Quinolone, Compared to Those of Other Agents 2005 ·Antimicrobial Agents and Chemotherapy ·Tatiana Bogdanovich, Duygu Eşel, Linda M. Kelly, Bülent Bozdoğan, Kim Credito, Gengrong Lin, Kathy Smith, Lois M. Ednie, Dianne B. Hoellman, Peter C. Appelbaum	31
13	Antipneumococcal Activity of Dalbavancin Compared to Other Agents 2005 ·Antimicrobial Agents and Chemotherapy ·Gengrong Lin, Kathy Smith, Lois M. Ednie, Peter C. Appelbaum	16
14	Antistaphylococcal Activity of LBM415, a New Peptide Deformylase Inhibitor, Compared with Those of Other Agents 2004 ·Antimicrobial Agents and Chemotherapy ·Kim Credito, Gengrong Lin, Lois M. Ednie, Peter C. Appelbaum	26
15	Antipneumococcal Activities of Two Novel Macrolides, GW 773546 and GW 708408, Compared with Those of Erythromycin, Azithromycin, Clarithromycin, Clindamycin, and Telithromycin 2004 ·Antimicrobial Agents and Chemotherapy ·(unknown), Klaudia Kosowska, Bülent Bozdoğan, Linda M. Kelly, Kathy Smith, Lois M. Ednie, Gengrong Lin, Kim Credito, Catherine L. Clark, Pamela McGhee, Glenn A. Pankuch, Michael R. Jacobs, Peter C. Appelbaum	9
16	Activities of Two Novel Macrolides, GW 773546 and GW 708408, Compared with Those of Telithromycin, Erythromycin, Azithromycin, and Clarithromycin against Haemophilus influenzae 2004 ·Antimicrobial Agents and Chemotherapy ·Klaudia Kosowska, Kim Credito, Glenn A. Pankuch, Dianne B. Hoellman, Gengrong Lin, Catherine Clark, Bonifacio Dewasse, Pamela McGhee, Michael R. Jacobs, Peter C. Appelbaum	16
17	Comparative in vitro activity of gemifloxacin to other fluoroquinolones and non-quinolone agents against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in the United States in 1999–2000 2002 ·International Journal of Antimicrobial Agents ·Laura Koeth, Michael R. Jacobs, Saralee Bajaksouzian, (unknown), Gengrong Lin, Peter C. Appelbaum	10
18	Effects of Various Test Media on the Activities of 21 Antimicrobial Agents against Haemophilus influenzae 2002 ·Journal of Clinical Microbiology ·Michael R. Jacobs, Saralee Bajaksouzian, Anne Windau, Peter C. Appelbaum, Gengrong Lin, D. Felmingham, (unknown), Laura Koeth, Mendel E. Singer, Caryn E. Good	14
19	Activity of HMR 3647 Compared to Those of Six Compounds against 235 Strains of Enterococcus faecalis 1999 ·Antimicrobial Agents and Chemotherapy ·Dianne B. Hoellman, Gengrong Lin, Michael R. Jacobs, Peter C. Appelbaum	11
20	Postantibiotic Effect and Postantibiotic Sub-MIC Effect of Levofloxacin Compared to Those of Ofloxacin, Ciprofloxacin, Erythromycin, Azithromycin, and Clarithromycin against 20 Pneumococci 1998 ·Antimicrobial Agents and Chemotherapy ·S K Spangler, Gengrong Lin, Michael R. Jacobs, Peter C. Appelbaum	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact